ea0081p432 | Pituitary and Neuroendocrinology | ECE2022
Fleseriu Maria
, Zhang Zhaoyun
, Hanman Kate
, Haria Keval
, Houchard Aude
, Khawaja Sheila
, Ribeiro-Oliveira Antonio
, Gadelha Monica
Background: Acromegaly is a rare disorder characterized by excess growth hormone (GH) and insulin-like growth factor 1 (IGF-1). Extended dosing intervals (EDIs) of pharmacological treatments may reduce patient burden and costs compared with standard dosing. This systematic literature review (SLR) investigated treatment of acromegaly at EDIs.Methods: MEDLINE/Embase/the Cochrane Library (2001June 2021) and key congresses (20182021) were searche...